As of Apr 01
| +0.03 / +0.30%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a -74.67% decrease from the last price of 9.87.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.